4
Changes in Ownership
Krystal Biotech, Inc. Filed Acc 0001209191-19-057590
Chief Financial Officer acquired 6,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Riley Antony A · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-11-19 | Exercise or conversion : show line 1 in the form | +6,250 | $9.85 | $61,563 | 9,050 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-11-19 | Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) | −6,250 | 18,750 | D |
Loading xslF345X03/doc4.xml…